German Stock Market: Whose Results Are Deceptive?
Numbers don't lie, but they don't always tell the whole truth either. The spring first-quarter reports have long been published by major German companies, and now, at the end of May, the initial dust on the markets has settled. As summer approaches and investors will soon begin shifting their focus to second-quarter expectations, now is the perfect time to look back and analyze what was actually hidden behind the spring numbers. We examine three well-known major German corporations whose headline profit numbers for the first quarter of 2026 are heavily distorted by extraordinary events.
FMEFresenius Medical Care (FME)
Fresenius Medical Care's first-quarter headlines might have startled investors at first glance, as the company's reported operating profit fell by 13.6% year-over-year, landing at 286 million euros. Net profit also dropped by 21.9%, and revenue decreased by 5.5%. Following the growth trend of the previous quarter, this seemed like a sharp setback, briefly driving the stock price to a one-year low in early May.
In reality, however, this profit decline is planned and temporary, as the numbers include one-off costs from the FME25+ transformation program and major strategic IT investments. Excluding these extraordinary expenses, the company's underlying profit actually grew by 2.0%. For investors, this means that the company's core business is more stable than the initial numbers suggest, and the ongoing savings programs should instead support profitability in the long run.
Create a free account to continue
Registration is free - the full analysis with all companies and the conclusion is waiting in the app.
Free account - no credit card needed
The information provided is not investment advice. RYTM analyses are generated with AI assistance and are intended for informational purposes only. Always do your own research before making investment decisions.